Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.
The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.
Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.
Funds from the fresh issue will be used for
The Company will utilize fresh issue proceeds to funding capital expenditures requirements for expansion of Dahej Manufacturing facility, to upgrade R&D facilities in Vadodara and to fund general corporate purposes.
Company Financials: (in crores)
How to apply for an IPO/Buyback Online via Navjeevan?
Step 1: Go to our website and select an IPO that you wish to apply for.
Step 2: Log in your details (Non-Navjeevan Client can log in via their mobile number).
Step 2: Enter the price at which you want to apply for shares and the number of lots and provide your UPI ID
Step 4: Submit the application and then approve the block funds request on the UPI App.